Prof. Isasi’s research is devoted to identifying and analyzing the social, ethical and policy dimensions of novel and disruptive genetic technologies. She has built an international reputation as a scholar with particular expertise in the area of international comparative law and ethics regarding genomics and regenerative medicine.
She holds many leadership roles in major international initiatives. Prof. Isasi was recently named the President’s International Fellow of the Chinese Academy of Sciences (CAS). She is Co-Investigator and Ethics/Regulatory/Communications lead for the SouthEast Enrollment Center (SEEC) a consortium member of the NIH’s All of Us Research Program. In addition, she serves as the Ethics/Policy Advisor of the European Commission’s European Human Pluripotent Stem Cell Registry (hPSCREG), is a member of the Ethics Advisory Board of the “Vanderbilt-Miami-Meharry Center of Excellence in Precision Medicine and Population Health” and the American Society for Human Genetics (ASHG) Task Force on “Gene Editing”. Finally, she is a member of the Ethics & Policy Committee of the International Society for Stem Cell Research (ISSCR) and is the Chair of the International Stem Cell Forum (ISCF) Ethics Working Party, a consortium of funding agencies for regenerative medicine.